from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0849/-

LFCtreatmentdescriptionclass of inhibitor

-0.057

Amikacinug/mL Amikacintranslation

-0.274

Cap5-10ug/mL Capreomycintranslation

-0.382

Rox10-50 ug/mL Roxithromycintranslation

-0.166

SM2-5 ug/mL Streptomycintranslation

0.014

Tet5-10 ug/mL Tetracyclinetranslation

-0.037

Rif0.2-5ug/mL Rifampicintranscription

-0.395

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.000

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.218

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.166

CPZ10-50 ug/mL Chlorpromazinerespiration

0.000

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.263

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.000

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.000

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.989

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.000

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.389

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.000

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.377

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.823

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-1.677

Nigericin50 uM Nigericinrespiration

-0.295

TRC10-150 ug/mL Triclosanrespiration

0.000

TRZ10-25 ug/mL Thioridazinerespiration

0.027

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.818

menadione6-10 ug/mL Menadionerespiration

-0.225

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.534

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

2.488

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.546

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.232

NRP_1Non-replicating persistence stage 1dosRassociated

-0.254

Amp0.2mg/mL AmpicillincellWall

0.412

Cephalexin20-100 ug/mL CephalexincellWall

0.214

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.802

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.113

EMB10-20 ug/mL EthambutolcellWall

0.103

Eta12-40 ug/mL EthionamidecellWall

0.271

INH0.2-0.4 ug/mL IsoniazidcellWall

0.461

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.185

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.456

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.729

BZA0.12 mg/mL BenzamidearomaticAmides

-0.427

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.293

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.139

H2O24 mM hydrogen peroxideDNAdamaging

-0.263

Levo10 ug/mL LevofloxacinDNAdamaging

0.082

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.460

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.182

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.265

UVUV-irradiationDNAdamaging

3.681

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.109

Antimycin12.5-50 ug/mL Antimycin A?

-1.733

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.878

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.066

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.433

PA8240.2-2 ug/mL PA-824?

0.096

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.004

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.138

Verapamil50 uM Verapamil?

-1.341

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.254

methoxatin10-20 ug/mL Methoxatin?